Hepion Pharmaceuticals, Inc. (HEPA) Earnings
Hepion Pharmaceuticals, Inc. is expected to report next earnings on October 14, 2026 (in NaN days), with a consensus EPS estimate of $-190.00. HEPA has beaten EPS estimates in 4 of its last 8 reported quarters (average surprise +67.5% over the last four).
Next earnings
Oct 14, 2026in NaN days
EPS est $-190.00 · Revenue est —
Track record
Beat EPS in 4 of 8 quarters
Avg surprise +67.5% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Aug 13, 2026 | $-200.00 | $-0.08 | +100.0% | — | — |
| May 14, 2026 | $-200.00 | $-0.07 | +100.0% | — | — |
| Mar 11, 2026 | — | $-0.07 | — | — | — |
| Nov 12, 2025 | — | $-0.04 | — | — | — |
| Aug 15, 2025 | — | $-0.09 | — | — | — |
| May 19, 2025 | — | $-2.15 | — | — | — |
| Nov 14, 2024 | $-95.00 | $-36.00 | +62.1% | — | — |
| Apr 16, 2024 | $-131.50 | $-121.00 | +8.0% | — | — |
| Nov 20, 2023 | $-134.00 | $-137.00 | -2.2% | — | — |
| Aug 14, 2023 | $-3.32 | $-184.00 | -5442.2% | — | — |
| May 12, 2023 | $-3.60 | $-174.00 | -4733.3% | — | — |
| Nov 14, 2022 | $-0.17 | $-110.00 | -64605.9% | — | — |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.